MBX Biosciences, Inc. (MBX) Stock Research

MBX Biosciences, Inc.

· MBX

Dashboard

Financials

Ratios

Valuation

Statistics

2.823 B

-3.53%

Today

MBX Biosciences price target raised by $62 at Guggenheim, here's why

6:46 AM

Over a week ago

MBX Biosciences doses first patient in oPTimize clinical trial

Aug 27, 8:09 AM

MBX Biosciences reinstated with an Overweight at JPMorgan

Aug 21, 6:26 AM

MBX Biosciences price target raised by $18 at Truist, here's why

Aug 10, 10:12 AM

MBX Biosciences price target raised by $18 at Barclays, here's why

Aug 7, 6:16 AM

MBX Biosciences reports Q2 EPS (78c), consensus (59c)

Aug 6, 9:20 AM

MBX Biosciences price target raised by $34 at Mizuho, here's why

Jul 29, 7:48 AM

MBX Biosciences price target raised to $90 from $60 at UBS

Jul 23, 9:37 AM

Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement

Jul 13, 7:41 PM

MBX Biosciences CEO Kent Hawryluk steps down, Steve Hoerter succeeds

Jul 13, 4:17 PM

MBX Biosciences down 19% at $30.05 after announcing canvuparatide study results

Jun 12, 8:19 AM

MBX Biosciences announces results from Avail, canvuparatide trials

Jun 12, 7:09 AM

MBX Biosciences price target raised by $6 at Stifel, here's why

May 12, 8:00 AM

MBX Biosciences price target raised by $4 at Barclays, here's why

May 12, 5:57 AM

MBX Biosciences price target raised by $10 at Citizens, here's why

May 12, 5:42 AM

MBX Biosciences price target raised by $20 at Truist, here's why

May 11, 9:51 AM

MBX Biosciences Phase 1 data supports once-monthly dosing for MBX 4291

May 11, 9:14 AM

MBX Biosciences appoints Mark Soued as chief commercial officer.

May 7, 9:30 AM

MBX Biosciences reports Q1 EPS (51c), consensus (58c)

May 7, 9:02 AM

MBX Biosciences initiated with bullish view at LifeSci Capital

Mar 31, 7:43 AM

MBX Biosciences files automatic mixed securities shelf

Mar 12, 4:09 PM

MBX Biosciences reports Q4 EPS (49c), consensus (63c)

Mar 12, 8:03 AM

MBX Biosciences appoints Basbaum as Chief Business Officer

Mar 10, 8:15 AM

MBX Biosciences 'on track' to initiate Phase 3 in Q3 following EOP 2 meeting

Mar 9, 8:06 AM

MBX Biosciences initiated with bullish view at Barclays, here's why

Jan 27, 4:26 PM

Charts